Danimer Scientific, Inc. DNMR
0.35 USD 0.00 (+0.00%)
At closeDec 30, 2025, 4:00 PM EST
0.325 Day range 1.13
2.45 52-week range 73.60
- YTD
- -83.33%
- 1 year
- -91.53%
Analyst view
Consensus: hold
Hold
Price target (mean) 4.67 +1233.3% upside
Now 0.35
- Target (low)
- 4.00
- Target (mean)
- 4.67
- Target (high)
- 5.50
Ratings (0m) 3 0 buy · 2 hold · 1 sell
- Strong buy0
- Buy0
- Hold2
- Sell0
- Strong sell1
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -7.10 | -7.77 – -6.43 | -15.45 | +54.0% | 11.05M | +1.3% | 2 |
| Next quarter | -6.17 | -7.21 – -5.12 | -10.00 | +38.4% | 14.00M | +37.0% | 2 |
| Current year | -32.11 | -32.55 – -31.66 | -60.46 | +46.9% | 40.36M | -13.6% | 2 |
| Next year | -18.75 | -24.77 – -12.73 | -32.11 | +41.6% | 85.57M | +112.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 21, 2024 | Piper Sandler | Maintained | Neutral | Neutral |
| Aug 13, 2024 | TD Cowen | Downgrade | Buy | Hold |
| May 22, 2024 | Jefferies | Downgrade | Buy | Hold |
| Apr 9, 2024 | Piper Sandler | Downgrade | Overweight | Neutral |
| Apr 4, 2024 | TD Cowen | Maintained | Buy | Buy |
| Oct 11, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Jun 1, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Apr 3, 2023 | Piper Sandler | Maintained | — | Overweight |
| Oct 12, 2022 | Piper Sandler | Initiated | — | Overweight |
| Sep 23, 2021 | Cowen & Co. | Initiated | — | Outperform |